For an oncologist, the time between a patient leaving the consultation room and the next one arriving is often spent staring at a screen, not a person. It is a silent, administrative interval where the nuance of a conversation,the hesitation before a prognosis, the specific phrasing of a side effect,must be translated into a structured clinical note. This documentation burden is a global constant in oncology, a specialty where patient journeys are long, decisions are high-stakes, and the emotional weight for clinicians is already immense. Helsinki’s Gosta Labs is building an operating system designed to vanish that interval, using ambient artificial intelligence to listen, draft, and structure patient data in real time [Gosta Labs, retrieved 2025]. The company has raised an estimated $10.7 million (€10 million) to date, with a €7.5 million seed round led by Voima Ventures closing in November 2025 [Tech Funding News, November 2025].
A Second Act in Structured Cancer Data
The bet is not the founders’ first in the cancer care technology space. Lauri Sippola and Henri Viertolahti previously founded Kaiku Health, a digital health company focused on patient-reported outcomes that was acquired by Swedish precision radiation medicine firm Elekta in 2020 [Gosta Labs, retrieved 2025]. That exit provides a tangible track record for investors in the notoriously difficult regulated healthtech sector. It also informs Gosta’s specific focus. Where Kaiku centered on the patient’s voice outside the clinic, Gosta aims to capture and structure the clinician’s work inside it. The company’s leadership, including Chief Medical Officer Dr. Lionel Hadjadjeba and COO Reetta Arokoski, brings decades of experience in scaling cancer-care technologies internationally [Perplexity Sonar Pro Brief, 2025]. This is a team that understands the regulatory contours and clinical workflows of oncology, a field where error tolerance is near zero.
The Ambient Operating System
Gosta’s product is an AI assistant that functions as a silent participant in the consultation. It listens to the natural conversation between clinician and patient, automatically generating a draft clinical note. The system’s more ambitious function is to transform that unstructured dialogue into structured data, summarizing patient journeys and linking care decisions to international treatment guidelines [Gosta Labs, retrieved 2025]. The company claims this can cut documentation time by more than two-thirds, though specific validation studies have not been made public [Tech Funding News, November 2025]. The technical foundation involves proprietary, task-specific language models trained, in part, on Finland’s LUMI supercomputer since early 2024 [Tech Funding News, November 2025].
Traction is emerging across a geographically diverse, if not yet fully named, set of early adopters. The company states its system is in use with healthcare providers in Finland, Switzerland, the Baltics, and Australia [Tech Funding News, November 2025]. One publicly confirmed deployment is with Finland’s Western Uusimaa Wellbeing Services County, which has implemented the solution in a health center to reduce paperwork and give doctors more time with patients [Western Uusimaa Wellbeing Services County, retrieved 2026]. The funding history shows a steady progression from concept to scaled deployment.
2024 Pre-seed | 1.7 | M EUR
2025 Seed | 7.5 | M EUR
The Skeptic’s Checklist
For all its promise, Gosta’s path is lined with the hard questions that face any clinical AI company aiming for global scale. The competitive landscape includes well-funded players like PathAI, which focuses on pathology, and RISA Labs, though Gosta’s wedge in ambient documentation for complex care is distinct. The primary hurdles are not technological but practical and regulatory.
- Clinical validation. Claims of slashing documentation time are compelling, but peer-reviewed evidence of accuracy, clinician adoption, and, most critically, impact on patient outcomes is the currency of trust in medicine. The absence of published studies means the product’s efficacy is currently a private promise.
- Regulatory navigation. An AI system that influences clinical notes operates in a highly regulated space. While Europe’s MDR and the FDA’s SaMD pathways provide frameworks, clearance is a costly and time-intensive process that Gosta will need to navigate for each major market.
- Integration depth. Success depends on more than just listening; it requires deep, bidirectional integration with hospital electronic health record (EHR) systems. Each health system’s unique EHR architecture represents a significant implementation challenge.
- Market specificity. Oncology is a smart beachhead,complex, data-rich, and burdened,but it is also a specialized field. Expansion into other complex specialties will require retraining and re-validation, not just a rebranding of the core technology.
The company’s prior experience with Kaiku Health suggests a team familiar with these hurdles, but they remain formidable.
The Standard of Care Today
The patient population here is dual: the oncologist drowning in administrative work, and the cancer patient who deserves their clinician’s full attention. Today, the standard of care for clinical documentation in most oncology settings remains manual entry into an EHR, often after hours. This clerical load contributes directly to physician burnout, a well-documented crisis in healthcare that can shorten careers and impact the quality of care. For the patient, it can mean a clinician who is physically present but cognitively exhausted, or notes that fail to capture subtle but important details discussed in the room. Gosta Labs is betting that by returning the gift of time and focus to the clinician, it can improve the experience and potentially the outcomes for both. The next twelve months will likely see the company working to convert its early international deployments into published case studies and seeking the regulatory approvals necessary to move from a promising tool to a standard part of the oncology toolkit.
Sources
- [Gosta Labs, retrieved 2025] Gosta Labs - AI Agents Built For Oncology | https://www.gostalabs.com/
- [Tech Funding News, November 2025] Gosta Labs lands €7.5M to bring AI precision to cancer care | https://techfundingnews.com/gosta-labs-raises-7-5m-to-scale-ai-oncology-precision/
- [FAIR EDIH, December 2025] Finnish Healthtech Startup Gösta Labs Secures €7.5 Million to Transform Cancer Care with AI | https://www.fairedih.fi/finnish-healthtech-startup-gosta-labs-secures-e7-5-million-to-transform-cancer-care-with-ai/
- [Western Uusimaa Wellbeing Services County, retrieved 2026] AI Assistance in Recording Client and Patient Information | https://www.luvn.fi/en/ai-assistance-recording-client-and-patient-information
- [Perplexity Sonar Pro Brief, 2025] Gosta Labs company briefing | (web-grounded research summary)
- [ArcticToday, retrieved 2026] Healthcare AI startup Gosta Labs secures €1.2 million pre-seed funding | https://www.arctictoday.com/%F0%9F%87%AB%F0%9F%87%AE-healthcare-ai-startup-gosta-labs-secures-e1-2-million-pre-seed-funding/